Answers are grounded in this paper and cite their sources.
The interim recommendation might be updated over the coming weeks based on additional safety and efficacy data from phase III clinical trials and conditions of FDA Emergency Use Authorization.
No takes yet. Share an insight, caveat, or question.
Dooling et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: